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Executive Summary
The main findings of this report are that: 
▶  There is presently a lack of fit between 
research, policymaking and service 
provision in relation to steroid use in 
Australia;
▶  The current prevalence of steroid use in 
Australia is unclear but appears to be 
increasing;
▶  There is an appreciable risk of blood-borne 
virus (BBV) transmission among people 
who inject steroids;
▶  More research is required in relation to:
>  Prevalence of use;
>  Motivations for use;
>  Issues around sourcing and supply;
>  The relationship (if any) between 
steroid use and other forms of illicit and 
injecting drug use;
>  The harms associated with steroid use, 
including but not limited to the risk of 
BBV transmission;
>  The minutiae of injecting practices 
among people who inject steroids; and
>  Knowledge of harms, including risks 
associated with particular injecting 
practices;
▶  A more targeted harm reduction strategy 
is needed for people who use steroids, 
including those who inject them; 
▶  Targeted harm reduction strategies 
must take into account the changing 
demographics of use, with younger men 
and culturally and linguistically diverse 
This report details findings from a national consultation on illicit steroid use in Australia 
undertaken between late 2014 and early 2015. The report presents findings from interviews 
conducted with a range of stakeholders, including academics, policymakers, service providers, user 
group representatives and other advocates. These interviews explored the phenomenon of steroid 
injecting along with the contemporary landscape of research, policy and practice in the Australian 
context. Interview questions were concerned with future directions for research on illicit steroid 
use, the relationship between research and policy, the relationship between drug services and 
policy implementation, and the most appropriate public health responses. This report presents 
participants’ perceptions of steroid injecting, key risks and responses, and needs for future research. 
The report also details participants’ perceptions of the landscape of steroids-related research, policy 
and practice in Australia, including the extent to which these three fields are sufficiently integrated, 
and where appropriate, strategies for improving the interface between these spheres of practice. 
groups, among others, using illicit steroids; 
▶  Some recent policy, legal and regulatory 
responses to steroid use in Australia have 
been implemented too hastily, without 
a sufficient evidence base and in ways 
that may be counter-productive to harm 
reduction; and
▶  There are barriers and enablers to 
engaging with people who use illicit 
steroids, both for the purposes of improving 
our knowledge base and for harm reduction 
and safer injecting strategies. 
This report is intended to inform researchers 
in the field of alcohol and other drugs, 
policymakers and service providers, 
advocates and user groups and relevant 
industries (such as the gym/fitness industry). 
The report documents areas of agreement 
and disagreement between stakeholders 
on the nature, and extent of steroid 
use in Australia; areas requiring further 
investigation; and perceptions about the 
barriers and enablers to integration between 
research, policy and practice and translation 
of research findings. As such the report aims 
to act as a guiding resource for future work in 
this area.
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1 Background and Aims
1.1 Background
A range of evidence suggests that illicit steroid 
injecting in Australia is increasing. These include:
▶  A 2014 major investigative report  by the Australian 
Crime Commission into drug use in Australian sport 
(Australian Crime Commission 2013a); 
▶  Data suggesting that customs interceptions of 
performance and image enhancing drugs (PIEDs) 
doubled between 2010 and 2011, increasing again in 
2011-2012 (Australian Crime Commission 2013b), 
with more than 70% of detected PIEDs being 
steroids (Australian Crime Commission 2013b);
▶  Steroid seizure and arrest data. These show 
substantial increases in the number and size of steroid 
seizures, alongside an increase in steroid-related 
arrests, with record numbers of seizures and arrests in 
2011-12 (Australian Crime Commission 2013b);
▶  Within the same timeframe, a doubling in the 
number of PIED injectors presenting at needle and 
syringe programs (NSPs) (Iversen et al. 2013);
▶  Reports that in some areas, PIED users now 
comprise the largest cohort of NSP service users 
(Iversen et al. 2013); and
▶  Data suggesting that among new initiates to 
injecting drug use (IDU), more than half (55%) 
reported last injecting PIEDs (Iversen et al. 2013). 
Similar trends have been reported in the United States 
and the United Kingdom, (Advisory Council on the 
Misuse of Drugs 2010a; Castillo & Comstock 2007; 
McVeigh, Beynon & Bellis 2003; Rich et al. 1998), and 
concern is increasing about how best to respond to 
them. Steroid use has become a particular concern 
for many reasons. In Australia, a key reason for this 
is the aforementioned ‘spike’ in steroid seizures and 
arrests by customs. Australia’s National Drug Strategy 
Household Survey (Australian Institute of Health 
and Welfare 2014) suggests that overall prevalence 
of steroid use remains low, with just 0.1% of those 
surveyed having used steroids for non-medical 
purposes in the previous 12 months. This figure is 
unreliable, however, given the high ‘relative standard 
error’ (Australian Institute of Health and Welfare 2014), 
so that prevalence might be either lower or higher than 
0.1%. Emerging alongside concerns that steroid use is 
on the rise in Australia are observations that the range 
of people using steroids is becoming more diverse 
(Evans-Brown & McVeigh 2009).  In other words, 
despite extensive media and public interest in PIED 
use amongst professional sportspeople, data suggest 
that the majority of use occurs among other groups 
(e.g. Bahrke & Yesalis 2004). 
Although there is a body of literature on steroid use in 
Australia, there has been less research in recent years 
that examines these apparent trends. The research 
team sought to explore some of the issues surrounding 
the apparent rise and diversification of steroid use in 
Australia with key stakeholders and analysts, with a 
view to guiding research in this nascent field. For this 
purpose, a national consultation was held between late 
2014 and early 2015. 
1.2 Overview of  
this consultation
The principal aim of the consultation was to document 
stakeholder perspectives on the current landscape of 
research, policy and practice in Australia in relation to 
steroid use, with a view to informing future research 
strategies in the field. The consultation’s aims and 
specific fields of inquiry are listed in Section 1.3 of this 
report. In particular, the report identifies several areas 
that warrant further research. These relate to gaps in 
research and/or translation of findings into policy and 
practice, and barriers and enablers to the development 
of research as well as to the identification and rollout 
of effective harm reduction strategies. 
In all, fifteen professionals based in a range of 
organisations participated in the research. The 
participants included researchers and academics, 
policymakers, advocates and service providers. An 
anonymised list of participants and the professional 
categories each represents appears in Appendix 
A. Some participants work across more than one 
category (e.g. service provision and policy). Where 
participants nominated more than one role, they were 
allocated to the category that most closely related to 
their work.  
Candidates for inclusion in the consultation were 
identified through criteria and methods including the 
authors’ combined knowledge of the field, a media 
analysis identifying active spokespersons on issues of 
steroid use, and invitations issued to major relevant 
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government departments in states and territories and 
at the Commonwealth level. Potential participants 
were sent written invitations (email or post) to join the 
study (Appendix B). More detail on the methods for 
the study can be found in section 1.4 below. 
1.3 Consultation aims 
The aims of the consultation were to explore: 
▶  Key issues for research into steroid use in Australia 
and for appropriate and effective social and public 
health responses;
▶  Gaps in Australia’s knowledge about steroid use; 
▶  Views on the degree of fit between research on 
steroid use and policy and practice in Australia; 
▶  Views on the scale of steroid use in Australia; and
▶  Strategies for feeding back research to policy and 
service delivery in this area.
1.4 Methods 
The interviews were conducted face-to-face or over the 
phone, digitally recorded and transcribed verbatim. 
All interviews were conducted by one member of 
the research team (Dean Murphy). Participants 
were asked a series of set questions (Appendix C) 
exploring perceptions of the scale of steroid use in 
Australia, appropriate measures and responses and 
needs for future research. At the conclusion of the 
interview, participants were invited to make additional 
comments or speak to topics that had not been 
covered. All interview transcripts were closely read by 
two of the authors and a series of preliminary themes 
were identified. In order to elucidate some aspects of 
the findings, quotations from participants are included 
in the sections that follow. In order to ensure the 
anonymity of participants, no participants are named 
in Appendix A of this report. Where quotations are 
included, they are attributed using only a category 
designation, being ‘SP’ for service provider, ‘PO’ for 
policy, ‘AD’ for advocacy and ‘RE’ for research. 
This project was approved by Curtin University’s 
Human Research Ethics Committee (Approval 
number: RDHS-09-14). 
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2.1 Trends in steroid  
use in Australia
Most participants in this consultation observed that 
the nature and scale of steroid use in Australia has 
not yet received sufficient attention from researchers, 
policymakers and service providers, and that 
considerable scope exists for more work — including 
more policy and practice relevant research — to be 
done in this area. The prevalence of illicit steroid use 
and the composition of the population that uses them 
were identified as two of the most crucial pieces of 
missing information.
2.1.1 Prevalence of use
Participants were asked to comment about the scale 
of steroid use. Most expressed the view that it has 
increased over time: use is ‘increasing for sure’ (AD3), it 
has ‘increased quite a lot’ (SP1) and — in terms of NSP 
attendance — is ‘rising, definitely rising — and fast’ 
(SP6). In contrast, some were more sceptical about the 
data, offering alternative explanations for the apparent 
increase in use, while cautioning against drawing any 
firm conclusions about prevalence. As one participant 
explained:
Look […] I don’t buy into [the claim] that every 
other second man is using steroids and I think 
we need to be very careful even using the NSP 
attendance data to say that, because I know for 
a fact that a decade ago, people wouldn’t have 
known [to go to] needle syringe programs. They 
would’ve much rather buy online or through a 
pharmacy […]  (AD1)
In relation to increases in customs seizure figures, the 
same participant noted:
[we] don’t always know that that’s a true indicator 
because what about what we’re not getting? Same 
with other substances, isn’t it? We don’t know 
what we’re not seeing, so it’s hard to use that as 
an indicator in and of itself around prevalence of 
use. (AD1)
While opinions on growing steroid usage differed, 
participants were nevertheless in agreement about one 
key point: that current knowledge about prevalence 
was hampered by a lack of reliable, up-to-date data. 
In some cases speculating that use was perhaps ‘very 
underrated’ (SP1), ‘a lot larger than people realise’ (SP1) 
and ‘bigger than what we think it is’ (SP2), participants 
called for more data to settle these questions. 
Concerned that ‘a lot of [the information] is wrong’ 
(SP1), participants suggested that Australia’s capacity 
to respond to steroid use is presently weak:
We don’t have a lot of visibility over what the 
extent of the problem is. (PO3)
We just don’t really know — do we — what the 
prevalence is. (SP7)
The need many felt for more data is summed up in this 
observation:
Certainly anecdotally and you look at the media 
you can see some stories suggesting that use is 
growing […] We are very reluctant to say that 
it has increased or that it is increasing, or it is 
in particular populations, because it always 
seems to be anecdotal. So we’d certainly support 
any study that could give better information 
about prevalence […] Certainly if we had better 
information on prevalence […] that would help us 
all as a sector to find effective responses. (PO2)
2.1.2 Who uses steroids in Australia?
As noted earlier, concerns have been raised both in 
Australia and internationally that the population using 
steroids is diversifying (e.g. Evans-Brown & McVeigh 
2009). Participants in this consultation agreed that 
this diversification is underway, with one noting that 
‘there was definitely a leap where suddenly, yeah, it 
got into the more general population’ (SP3). This has 
led, in another participant’s view, to ‘a change in drug 
tone’ (SP7). Some of the main groups thought to be 
using steroids in increasing numbers in Australia are 
detailed in Table 1, below.
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Participants also noted a tendency among AOD sector 
workers to make inaccurate assumptions about who 
uses steroids, especially as a result of this diversification. 
This diversification has implications for research as well 
as for other areas. As one participant explained:
Well, I think that we previously conducted work 
in this area and the thing that really stood out 
for me was that there were different typologies of 
steroid users that meant you need to think about 
your sampling frame, about which of those groups 
you are going to sample from and structuring 
your questionnaire around that framework. When 
we first started, we thought they were all going to 
be people who are in the gyms and that they were 
connected to that and we discovered that that 
wasn’t the case at all. (PO1)
As another participant explained: 
the market for steroid use is a lot broader than 
just gym junkies and body beautiful people and 
[… more research on] stuff around models and 
the occupational thing as well […] would be great 
because I think the, what we know, what we’ve 
seen in terms of people’s application and use is a 
lot broader than what is, well, what’s stereotyped 
as steroid users. (AD2)
As with the question of prevalence, there was a call for 
more reliable, up-to-date data on who uses steroids in 
Australia. 
Who uses steroids in Australia? Indicative quotations
Younger people We have cases of people who in their early 20s or even in their teens are already starting to use 
steroids, especially young men who are already bursting with testosterone anyway.  (AD2)
We are seeing a lot more young people who are willing to give it a crack. (PO3)
Culturally and linguistically 
diverse groups
They’re not all Anglo-Australians. (SP3)
Occupational groups There’s quite a huge construction industry happening in Gladstone at the moment with Port Curtis 
going ahead and lots of mining around as well, so there’s quite a large disposable income that we see 
in the mining, construction populations, so some of the steroid guys are coming from there. (SP5) 
People who work in […] distribution and what not, people who are having to carry heavy loads of 
things, people operating heavy machinery. (AD2)
Aspiring athletes I still see a lot of people that are playing amateur sport, but with a view to be professional. They might 
be late teens, early 20s and still think that one day they could be professional sports people. (AD1)
Table 1: Groups cited as using steroids in increasing numbers in Australia
“We don’t have a lot of visibility over what 
the extent of the problem is.”
(P03)
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2.2 Lack of fit between 
research, policy and practice
The issue that generated the most widespread 
agreement among participants in the consultation 
involved the relationship between research, policy 
and practice in this area and — in particular — the 
extent to which these three fields were integrated. 
Most participants were of the view that the level of 
integration between research, policy and practice in 
Australia is extremely low and that much more could 
and should be done to encourage dialogue between 
researchers, practitioners and policymakers, for more 
effective social and public health policy responses to 
steroid use. 
Some participants argued that there was a significant 
gulf between knowledge and practice, with research 
being ‘very underdone’ (AD1) and policy, practice 
and research described as being ‘very far apart’ (SP4). 
One senior policy official declared that ‘Australia 
hasn’t done anywhere near enough [work] in this 
space’ (PO1). Several participants expressed a sense of 
urgency to improve integration, a view perhaps best 
articulated by one participant who suggested that:
I can definitely say from my experience in here, 
that it has sort of, you know the horse has bolted 
from the stable about 10 years ago, where it just 
really took off. (SP3)
Participants identified gaps in research, policy and 
practice as well as levels of integration between all three:
Policy and practice is lacking. Lacking for a 
whole bunch of reasons. I think that there are a 
lot of assumptions made about steroid use and 
performance-enhancing drugs. (SP2)
To my knowledge, there would be nothing 
departmentally that would be you know, MSM 
or gay specific […] I don’t think there’s any kind 
of policy or anything like that to guide those of us 
that are working on the ground. (SP4)
…the gap in steroids is there’s just not the 
resources around as far as any TV awareness, no 
TV campaigns. There is the odd brochure here 
and there. (SP6)
Participants gave several examples of the lack of fit 
between research, policy and practice, along with areas 
where more research was needed. Several participants 
emphasized the importance of responding quickly, 
as ‘there’s a lot of catching up to do, because it’s all 
happening now and grows and changes very quickly’ 
(SP5). In the next sections, we examine two of these 
examples as a way of illuminating some of the core 
concerns of consultation participants.  
2.2.2 Harm reduction measures 
poorly integrated 
Participants in service provision and advocacy 
expressed particular concern about the lack of 
evidence to guide the work they do, with one 
participant explaining that ‘we feel really out of our 
depth’ (AD1). In other words: ‘How would we respond 
as a service, how do we respond to the 5% of our 
clients who are injecting steroids? 5% is a significant 
number’ (SP2). The need to provide more information 
and support to the AOD workforce was a strong theme 
across the consultation, as these comments indicate:
The educators and the needle exchanges know 
the education on drug and alcohol, but [are] very 
limited when it comes to steroids. (SP6)
There are some barriers that the client groups 
have because our services were not set up to 
support their drug of choice. Most of our services 
were set up in the 1980s when heroin was the 
predominant drug that was being injected and 
therefore, we have services that are very much 
focused on that client group.  (SP2)
We are getting information from our NSPs now 
that there’s increase in steroid users attending 
NSPs to get their syringes, but the whole issue for 
them around, it’s not their normal customer base 
and information you know, is not geared to that 
customer base. (PO3)
I think at the coalface you know with other 
workers or health workers that might be dealing 
with guys that have used steroids, their knowledge 
is quite low. (SP5)
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I really do think NSPs are geared towards other 
types of injecting, so there’s a lot of workers out 
there that don’t feel confident even having the 
discussion, because they you know, they might 
not have correct information to have a share, but 
actually gaps about knowledge of the use. (AD3)
As one participant explained, service providers could 
work more effectively if more research was available to 
guide them: 
research can step in and ask those questions, 
provide those recommendations on how a 
service should respond, whether that’s as 
an outreach model, whether it’s an in-reach 
modelled into broader community services, 
whether it’s a specialised program, sort of a 
bit like this one, but with them as a particular 
focus. Whether it’s working within gyms and 
other established services, whether it’s working 
within nightclubs and coming into people in 
the entertainment industry and those sorts of 
contacts. Whether it’s going out to building sites 
and working with people who are occupational 
users of steroids, because they’re another big 
group of steroids users. (SP2)
Participants suggested ‘a variety of things’ (PO1) 
researchers could examine that ‘nobody has looked 
at all’ (PO1), noting that a key priority was to support 
harm reduction strategies. As one participant noted, 
‘most of the people we had contact with wanted to 
have a safer steroid use’ (PO1), but asked, ‘how could 
research support that?’ (SP2). As these participants 
explained, service providers need much more support 
and training on steroid injecting practices and safety:
Things around you know, how to inject, where 
to inject and how to inject. Stuff around the 
differences in equipment between intravenous 
injection and intramuscular injection. Equipment 
you’ll use for different muscles, so you know, 
looking at different injection sites, the three main 
ones, being quads and […] glutes and thighs. 
And stuff around needle length, stuff around 
you know, how much you know, leaving some of 
the tip outside of the body, so if it’s a contracture 
muscle and the needle snaps you’ve got some 
metal to pull back on, just little things like that, 
and stuff around injection site care, stuff around 
what we know in terms of you know, steroids that 
might appear to have been produced in a sterile 
environment but actually haven’t been. (AD2)
2.2.1 Policy, legal and regulatory 
responses may generate or  
increase harms
Some participants compared the apparent lack of 
action in relation to harm reduction strategies and 
supports for service providers to the wave of action 
underway in law enforcement. Some Australian  
states have recently introduced legislative changes 
that carry more severe penalties for people who  
use or possess steroids. One participant argued  
that recent changes to the law in Queensland had 
been developed as a result of poorly evidenced 
perceptions about links between steroid use and 
aggression and violence:
While there’s been some research in relation to 
increased aggression for people who use steroids, 
there’s not a lot of firm research that states 
‘yes, it is a contributor’ or ‘no it’s not’, because 
that was one of the triggers for the Queensland 
Government increasing penalties associated 
with steroid possession and supply. It was the 
perception of its linkages to increased aggression 
and violence. (PO3)
Another participant observed that: 
There’s a number of people who do go out on the 
weekend who are pumped full of this sort of stuff 
and actually do these [violent] crimes, but it’s 
an extremely small proportion, but you know it’s 
blown all out of proportion and knee jerk reaction 
informs policy and it’s a complete mess […] I 
“We are catching up, there’s a lot of catching up 
to do, because it’s all very happening now and 
grows and changes very quickly.” 
(SP5)
2 Findings
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mean my issue with that is that this policy was 
informed by a bunch of assumptions, which I 
don’t think was based on true fact. (AD2)
The same participant took the view that policy 
responses based on unsustainable assumptions or 
misconceptions had the potential to generate harms. 
Stuff around you know misconceptions or 
misunderstandings around ‘roid rage’ and […]
I know we are talking about Australia and that, 
but looking at it from a NSW perspective, stuff 
around the current laws recently — the increase 
in severity around you know possession and 
sale of steroids and what not […] I’m thinking 
we are only going to effectively drive it further 
underground and make it harder for people like 
me to do my job and preach around harm […] 
so these kind of misconceptions then informing 
policy and it being disproportionate and unfair. 
You know, the concern for me is it driving people 
further underground and away from services that 
might otherwise be more able to assist. (AD2)
Overall  a strong sense emerged in the data that 
Australia urgently needs a broader and richer evidence 
base on steroid use to properly inform policy and 
practice:
we need some more clearer evidence-based 
research, or research that can inform evidence-
based decisions. (PO3)
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2.3 Gaps in knowledge  
about illicit steroid use
The consultation identified several gaps in existing 
knowledge about steroid use in Australia. These 
include those already mentioned pertaining to 
trends/patterns in use, but participants also 
highlighted other gaps in knowledge, many of  
which relate to the practices and motivations of 
people who use steroids in Australia. These are 
detailed below. 
2.3.1 Sourcing steroids and  
injecting equipment
Many participants suggested that there was a need 
to know more about accessing steroids and steroid 
injecting equipment, including ‘where [steroids] 
are being sourced’ (AD2) and ‘where they pick up 
[steroids] from, where they pick their needles up 
from’ (SP5). There was a perception that steroid  
use was becoming ‘very accessible’ (SP4), particularly 
via the Internet, supplement stores and through 
overseas ‘steroid holidays’:
And now people are able to quite easily it seems, 
you know access them online and from overseas, 
from their own initiative rather than them having 
to go through someone. (PO2)
The other one I guess is on-shore versus off-shore 
use, so the steroid holidays where people will 
go and do a cycle in South-East Asia, so that if 
they are competing in a sporting context or body 
building context, they will do their cycle overseas 
in time for it to sort of pass through the system 
so it won’t be detectable when they are actually 
competing.  (PO2)
A lot of the supplement stores that have popped 
up, a lot of reports from some of the guys, some 
of the stores are actually selling like the peptides 
when they are around a bit, so [there’s] a lot of 
use out there in the industry I guess, the fitness 
industry. (SP5)
We are in a modern age of technology, things 
are at our fingertips, information is at our finger 
tips […] I just googled ‘post-cycle treatment for 
steroids’ and found a site, went to the site and 
then this pop-up came up asking me if I wanted 
to purchase. (SP4)
2.3.2 Motivations for using steroids
While some research has been conducted on 
motivations for using steroids, many participants 
called for more research on this issue, especially 
as steroid use may be increasing and the base 
diversifying. Participants suggested a focus on whether 
‘it’s more image-related than performance’ (PO3), 
whether there is a relationship between ‘working in 
particular industries and the pressures around those 
forms of work’ (RE1), as well as motivations for use 
‘within their own cultural context’ (PO1):
I think motivations for use: what is it that actually 
drives people, and whether that be a young 
person who wants to be muscular for either 
aesthetic reasons or sporting reasons, to an older 
guy who has natural depletion of testosterone 
and he’s seeking to get some sort of youth back 
and has chosen an illicit way rather than, for 
example, get involved in some sort of testosterone 
replacement therapy. (AD1)
2.3.3 Relationship between  
illicit steroids and other drugs
A smaller number of participants called for more 
research into the relationship, if any, between steroid 
use and other forms of drug use, suggesting that it 
would be useful and ‘interesting to see what sort of 
profile it might have in regards to other drug use’ (AD1). 
One participant raised concerns about the possibility 
that steroid use might act as a kind of ‘gateway’ for other 
forms of illicit drug use and encouraged researchers and 
policymakers to consider these questions:
So, previously being injecting PIEDs, my guess is 
that maybe they wouldn’t have ever thought of 
using, of being an injecting drug user with regards 
to [other] illicit drugs, but then [I’d like to know] 
how that relationship with the syringe will change 
that. So would they be more likely to inject crystal 
than smoke it for example? (SP7)
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2.4 Gaps in understanding 
of the harms associated with 
steroid use
Many participants spoke about the harms potentially 
associated with steroid injecting, calling for more 
research into these questions. This included  
concerns about the harms that can be associated 
with injecting steroids, particularly blood-borne  
virus (BBV) transmission.
2.4.1 Harms associated with use
While some research exists on the harms associated 
with steroid use, several participants articulated a 
need for more work in this area to better understand 
‘the actual harms associated with injecting use of 
steroids’ (PO3) As one participant explained:
Well as usual, we sort of huff and puff about the 
harms. People though clearly find them very 
effective […] It would be nice to have a bit more 
hard data about percentages and so forth, but 
I guess it’s complicated and you’re relying on 
anecdote and if these products are you know, not 
pharmaceutically pure, then it’s hard to know 
exactly. (SP8)
Participants called for more reliable research on many 
aspects of steroid use including:
Stuff around health implications for long-term 
use. You know effects on organs, stress on your 
body, psychological factors, you know, stuff 
like body dysmorphia and you know also say, 
practices in terms of length of cycles and rest 
periods between cycles.  (AD2)
2.4.2 Blood�borne viruses
Steroids can be administered in a variety of ways, 
including orally, but evidence suggests that the majority 
of people who use illicit steroids inject them (Larance 
et al. 2008; Grace et al. 2001; Bolding et al. 1999). People 
who inject illicit drugs are at greatly increased risk 
of blood-borne virus infection. In Australia, hepatitis 
C is of particular concern among people who inject 
drugs (Fraser & Seear 2011). BBVs can be transmitted 
through the sharing of needles and/or ancillary injecting 
equipment. Some research has found equipment 
sharing among people who inject steroids (see Advisory 
Council on the Misuse of Drugs 2010b), but this evidence 
is patchy and inconsistent. One of the consultation 
participants noted that ‘there’s little if any evidence of 
sharing of equipment or sharing of vials’ (AD2) but felt 
that more research on this was needed (see Aitken, 
Delalande and Stanton 2002). Two participants (SP3, 
SP7) referred to recent UK-based research indicating 
that BBV prevalence among steroid injectors is higher 
than in the general population. These findings were 
cause for concern, suggesting that BBV transmission 
among people who inject steroids should be a priority for 
researchers, policymakers and service providers. 
There was a consensus that people who use steroids 
might inject with friends, share needles or ancillary 
injecting equipment. As with previous topics, 
participants expressed a concern about the lack of 
evidence on these issues. One participant noted that, 
unlike other harms often associated with steroid use 
(such as cardiovascular complications), the spread of 
BBVs within the steroid using community could ‘turn 
around and bite you in the next few years’ (SP8) if not 
addressed as a matter of urgency. Several participants 
shared stories about potentially problematic injecting 
practices, either from direct observation or contact 
with people who use steroids: 
The three cases that I’ve heard about recently, 
all had their steroids administered by a third 
party. All of them had what was described to be 
appalling injecting practices, so they hadn’t really 
swabbed down the area, they hadn’t waited for 
the alcohol solution to dry. (PO1)
A lot of the time guys are injecting each other, 
because they don’t see themselves at risk, they 
don’t take the precautions that they should 
with the blood and they’ll be making things 
up and things will get contaminated. Benches 
will get contaminated and there’s that cross-
contamination there.  (SP1)
I mean people have described blood everywhere 
from multiple insertions of small needles to the 
desired part, so it becomes multiply punctured 
[…] So it can be very messy and in terms 
of infection control and stuff, that’s a really 
unsavoury picture isn’t it?  (SP8)
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They’ll come [to NSPs] and get a box of 100 
barrels and yeah, they tend to get boxes rather 
than smaller amounts for day to day, and often, 
because we ask “is it just yourself or how many 
people, three or more?” and most of the time 
it would be three or more. Very rarely would 
someone be doing it on their own, which presents 
problems in terms of harm reduction stuff if 
they’re using with other people, just making sure 
they are not sharing. (AD3)
There was a strong consensus that information on the 
minutiae of injecting practices among people who 
use steroids is needed. This included ‘where they use’ 
(SP5), as well as initiation, patterns of use, and social 
aspects of use:
The injecting patterns for this population, the use 
patterns […] initiation into injecting PIEDs. Do 
people inject themselves? Are they injected by 
others? Do they inject others? I’m always really keen 
to understand that around any injecting process. 
You know, does it happen alone, is it happening in 
groups? What happens to the equipment? What’s 
their understanding of blood borne viruses? Are 
they being tested for hep C, hep B, HIV? (SP7)
One participant pointed researchers to previous work 
done with people who inject drugs, calling for similar 
new work with people who inject steroids:
If we go back to the early days when Nick Crofts 
[a leading Australian BBV researcher]  and 
others were videoing injecting techniques and 
seeing how crap people were in terms of self-
administration of drugs, that kind of work hasn’t 
been done amongst steroid users. (PO1)
2.4.3 Knowledge of  
injecting�related harms
While risky injecting practices elicited a great deal 
of concern among consultation participants, a 
matter of equal importance was knowledge of risk 
among steroid injectors. One participant said that 
people who inject steroids often ‘present with very 
low […] education around safe injecting and, you 
know, clean injecting and that sort of thing’ (SP4), 
with the Internet being ‘a great tool for information 
or misinformation’ (PO3). It was thought that many 
people who inject steroids rely on ‘word of mouth 
[…] and people just believe what they’re told’ (SP1). 
Several participants raised concerns about this 
process — the sharing of inaccurate information 
about use and safer injecting techniques:
Through what’s often called ‘Bro Science’, so it’s 
stuff that’s talked about in the gyms. (AD1)
This lack of knowledge about risks led one participant 
to conclude that ‘their biggest risk is that they don’t 
see themselves as a risk’ (SP1). Similar concerns were 
raised by others: 
I think they know that obviously not to share 
needles, I think that’s across the board […] They’d 
be way less informed of other factors, like you 
know, sharing other types of equipment other 
than just the actual needle. (AD3)
I’ve got a lot of people learning from their mates 
in the gym […] and sometimes those passed on 
skills or knowledge isn’t always the best.  (AD2)
I was struck by the fact that five years ago […] 
people were a lot more careful and I think what’s 
happened is that, there’s a sense that ‘well, bad 
things don’t happen and HIV is not an issue 
because we don’t inject drugs; we inject steroids’. 
(PO1)
That’s perhaps one of the quite striking things 
about men that I have seen that they appear 
at least on the surface to have a very detailed 
knowledge of these androgenic products, 
and perhaps that understanding is not really 
supported by scientific evidence, but nevertheless, 
they have a lot of views about how it should 
be administered and what the cycle should be 
and those sorts of details, which I think to most 
practitioners is rather bewildering, because, well 
to me, it doesn’t really make much sense.  (SP8)
“I’ve got a lot of people learning from their mates in the gym…” 
(AD2)
2 Findings
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2.5 Enhancing Australia’s 
capacity to understand and 
respond to steroid use
A common theme across the consultation was that 
Australia faces several key barriers to understanding 
and responding to steroid use, to undertaking research 
effectively and to integrating research, policy and 
practice. At the centre of this issue was a need to better 
engage with the people who inject steroids in Australia. 
2.5.1 Barriers to understanding  
and responding to steroid use
Participants offered a range of possible explanations 
for the lack of fit between research, policy and practice. 
These included an over-reliance on research from the 
United States and Europe, without enough research 
on the specificities within Australia, but also concerns 
about an erosion of resources for the alcohol and other 
drug sector in Australia more broadly:
I’ve found at a national level, all of the 
infrastructure that used to be in place that 
you could easily draw upon has just been 
systematically dismantled. You know cost-cutting 
has driven a lot of the reform, so the committees 
that used to exist and the networks aren’t there. 
(PO1)
A key barrier to understanding and responding to 
steroid use in Australia lies in difficulty accessing and 
engaging with steroid injectors. This was thought to be 
relevant to the current gap between research, policy 
and practice because it involves a ‘secretive’ (SP3), 
largely ‘hidden group’ (SP2) that injects ‘behind closed 
doors’ (SP1), and where ‘the reality is people often 
won’t disclose. There’s a real stigma’ (AD1). There was 
a general consensus that ‘we don’t really know very 
much about this population’ (SP7), and that more work 
needed to be done to engage with them: 
It’s a very difficult cohort to research.  (AD1)
They tend to get very wary about people who don’t 
look the part. (SP1)
Because it’s illegal what they’re doing, they’re 
frightened to go anywhere. (SP1)
I think they’re a group of people that don’t trust 
necessarily health services. (RE1)
Probably the biggest issue that I’ve noticed is […] 
the difficult nature of reaching the client group 
in terms of getting access for them and that trust 
and I think because they do see themselves as 
different. (AD3)
As well as hindering research, difficulties in accessing 
steroid injectors were thought to be linked to 
Australia’s capacity to provide effective safer injecting 
and harm reduction advice. There was a strong view 
among consultation participants that people who 
use steroids might not see any need to be involved 
in research and/or to receive harm reduction advice, 
because they do not see themselves to be at risk:
Probably because the steroid users don’t see 
themselves as an injecting drug user. Some of the 
guys come in and say: ‘look, I’m not a junkie but I 
need some needles’. (SP5)
Being steroid users, they don’t see themselves 
at risk of blood-borne viruses. As far as they’re 
concerned, you know some of the terms you’ll get 
out of their mouths is: ‘I’m not a junkie’, or ‘I’m 
not a drug user’, so they don’t see themselves at 
risk and in their injecting procedures, they put 
themselves at risk all the time. (SP1)
Yeah, I guess going back to what I previously 
stated around gay men not seeing it as a drug of 
misuse. You know, that it’s more of a health — it’s 
sort of perceived as a health supplement or a kick 
starter.  (SP4)
I think — it’s interesting when I’ve conducted 
clinical drug assessments, that when you mention 
steroids, clients don’t associate steroids with drug 
use. You know, you get this look ‘Oh, is it a drug?’ 
[…] people don’t see it as a drug or a substance 
that can be misused. (SP4)
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2.5.2 Strategies for researching  
and responding to steroid use
While participants identified unique challenges 
for understanding and responding to steroid use in 
Australia, they also agreed that this work  
Strategies Indicative quotations
Work on establishing trust [Injecting] steroids and performance-enhancing substances [occurs within a] community and so it’s 
about accessing their community and gaining the trust for them to talk with you. (PO2)
Engage with key stakeholders 
(1) — Industry
[Engagement with] the fitness industry is going to be really key (SP7)
Link in with some of the larger gyms that are renowned for steroid use (AD2)
Engage with key stakeholders 
(2) — User groups
Make sure that drug user organisations are included, [that] would be really good.  (SP7)
Engage with key stakeholders 
(3) — Community figures
Get in contact or find if possible, some of the gatekeepers in those communities as well, who then can 
distribute information on the study on their behalf (AD2)
Use multiple recruitment 
strategies
It’s not a population that particularly is incentivised by very small financial payments, I don’t think 
that’s a really — it’s ethical to do that of course — but I don’t think that’s the primary reason why 
people who inject performance-enhancing drugs participate in research. (SP8)
It would be ideal to also recruit study participants through online forums. It’s hard to know exactly 
who accesses these, but I would say that it seems to be a primary source of information on the range 
and function of PIEDs, as well as injecting techniques. (RE1)
It’s the needle syringe workers who are most likely to come in regular contact with these guys and you 
know, I think that is a well proven route for people to be able to access good advice and treatment or 
further referral opportunities, so I think building on that is probably one’s best move. (SP8)
Be sensitive in recruitment [Be] mindful of not stigmatising those who are completing the survey and [use] non-judgmental kind 
of language and that kind of stuff […] how many times I’ve come across final drafts of survey questions 
for things and I’m thinking, ‘Man, there are some really loaded questions here’, and you just be, yeah, 
careful of not putting off the people you are trying to source information from. (AD2)
Table 2: Strategies for researching and responding to steroid use
“[Engagement with] the fitness industry 
is going to be really key”
(SP7)
was needed. Several suggestions for how to  
access people — both for research purposes and 
for providing safer injecting and harm reduction 
information — were offered. These strategies are 
detailed in Table 2, below.
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2.6 Working towards more 
effective harm reduction 
strategies
Despite the many barriers to engagement described 
above, participants were confident that effective 
harm reduction strategies could be developed. As 
one explained, ‘a lot of risks could be mitigated with 
good information’ (SP2). Given that steroid use can be 
associated with certain harms, there was a consensus 
that Australia needed to take action to address them: 
If this is a community of people that are 
experiencing harms, then is there something that 
we can do to get better information to them?  
(PO2)
If we’re not giving them the ability to make an 
informed decision, then we as a society are 
lacking. (SP2)
To this end, many participants stressed the urgent 
need for engagement and educational work to be done, 
carefully grounded in research into the informational 
needs, concerns and experiences of people who use 
steroids. Existing safer injecting advice for people 
who inject other illicit substances was seen to be 
insufficient for the reasons mentioned above (i.e. that 
people who use steroids might not see themselves as 
people who inject drugs – PWID), so that many of ‘the 
messages out there for injecting drug users, don’t reach 
these guys’ (SP5). As one participant explained,
What the right model is, I don’t yet know. 
Hopefully, research will help us point to that, or a 
variety of options that need to be tried. (SP2)
Suggestions for more targeted and effective harm 
reduction strategies are detailed in Table 3, below.
Suggestions for future harm 
reduction strategies
Indicative quotations
Ensure messages acknowledge 
difference from other forms  
of IDU
They do see themselves as completely different to our client group and they do like to have it 
acknowledged that they are not the same.  (SP3)
The whole sense of exceptionalism — ‘we’re different’ — I think [is] absolutely right. I think there is a 
sense of that. However, that maybe gives us clues as to how a slightly different approach is needed, 
because the traditional routes for the intravenous, on the whole intravenous injectors we see in 
Australia, may pass us by completely because as you say, they’re different. So perhaps we need to 
develop a new language or a new way of targeting these individuals. (SP8)
Be creative in designing and 
delivering messages
They really think they’re quite a savvy community. So we were thinking that you’ve got to be much 
more nuanced in the kind of messages you give to them. (PO1)
Consider regulatory responses 
and options
I’d be really interested to know how gym owners view this whole thing and then how they, you know, 
any policy that might be made on a health regulatory even system, might influence them to do certain 
things. It might provide needle disposal units and have you know, something like swabs around.  (SP3)
Ensure formats are accessible 
and responsive to change
So it’s getting that information that’s there to the people that need it in a format that they can access 
and trust in a timely way. (SP2)
Getting effective education to people that are using or considering using performance-enhancing 
drugs that’s credible, reliable and in a format that is trusted and can be easily received. (SP2)
Ensure the message responds 
to needs and concerns of the 
cohort
In terms of image enhancement, which is a sort of an individual exercise, it sort of needs a different 
response and I don’t think — it’s a very challenging turf to find what the appropriate response and 
messaging is. (PO2)
Well I think we have to try trading on what’s important to them, which is their appearance. (SP8)
Table 3: Suggestions for developing more targeted and effective harm reduction strategies
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Conclusion
This report sets out findings from a national consultation on steroid use in Australia, undertaken 
between late 2014 and early 2015. The findings are based on interviews with a range of key 
stakeholders in policy, service provision, advocacy and research. Participants identified a clear 
lack of fit between research, policy and practice in Australia. 
They argued for more research that supported policy and service provision, and targeted harm 
reduction strategies in particular. The consultation found that most participants believe steroid 
use in Australia is on the rise, and that despite their best efforts to respond, many service 
providers feel unprepared to deal with these developments. Participants suggested a need for 
more research on prevalence as well as changing patterns of use. Although there has been little 
research in Australia on the relationship between steroid injecting and blood-borne viruses, 
particularly hepatitis C, most participants took the view that people who inject steroids are at 
risk of blood-borne virus transmission through the sharing of needles and ancillary equipment. 
Several participants recounted examples of unsafe and potentially risky injecting practices 
among people who inject steroids. They noted that people who use steroids often do not 
consider themselves to be at risk, because they associate injecting risks and hepatitis C with 
‘junkies’ and drug ‘addicts’. These findings suggest a need for more research on injecting practices 
among people who use steroids in Australia, with a special focus on BBV transmission risks. 
The consultation also found that researchers, policymakers and service providers face particular 
challenges in responding to steroid use in Australia. These include the difficulties in engaging 
with a changing and heterogeneous population of people, because steroid use is hidden, secretive 
and stigmatised. The consultation includes a number of practical recommendations for better 
engaging with these populations, both for the purposes of future research and for more targeted 
and effective harm reduction strategies. 
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Appendix A
Table of participants
No. Pseudonym Area State/Territory
1 PO1 Policy South Australia
2 SP1 Service Provision Victoria
3 AD1 Advocacy Victoria
4 SP2 Service Provision Victoria
5 SP3 Service Provision Victoria
6 SP4 Service Provision Victoria
7 SP5 Service Provision Queensland
8 PO2 Policy Victoria
9 SP6 Service Provision Western Australia
10 PO3 Policy Queensland
11 AD2 Advocacy New South Wales
12 RE1  Research New South Wales
13 SP7 Service Provision Tasmania
14 AD3 Advocacy New South Wales
15 SP8 Service Provision Queensland
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Appendix B
Letter of invitation
Dear [insert name of invited participant],
Invitation to participate in a national consultation on new research into the use of steroids in Australia:  
Ethics approval number: RDHS-09-14
We are a group of researchers developing a new research project on the use of steroids in Australia.  
We are particularly interested in ensuring our study is geared towards the contemporary needs of  
research and service provision in this area. 
As part of the preparation for this study, we have decided to conduct a consultation with key stakeholders,  
researchers and   who have made important contributions to this field. The proposed  
consultation will explore a number of matters related to steroid use, including:
Key issues for research into steroid use in Australia, and for appropriate and effective social  
and public health responses to steroid use;
▶ Potential gaps in Australia’s knowledge about steroid use; 
▶ The fit between research on steroid use and policy and practice in Australia; 
▶ Views on the scale of steroid use in Australia; 
▶ Strategies for feeding back research to policy and service delivery in this area.
One purpose of this work is to help us shape and refine our proposed research.
Participation in this consultation will involve a telephone or in-person interview of approximately  
30 minutes’ duration, to be arranged at your convenience. 
At the end of the process, a report will be produced and circulated to all participants, as well as made publicly 
available. We will also produce a research paper out of the consultation to be published in a peer-reviewed journal. 
If you are able to be involved, or have any questions about the consultation and wish to know more, please contact Dr 
Dean Murphy (Consultation Coordinator) by email: Dean.Murphy@curtin.edu.au  
We look forward to speaking with you.
Yours sincerely,
Dr Kate Seear (Chief Project Investigator, on behalf of the research team) 
Adjunct Research Fellow,  
National Drug Research Institute, Curtin University, Melbourne Office
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Appendix C
Questions for participants
1.  How would you describe your work? How does it 
relate to steroids?
2.  What do you consider to be the key issues for 
social research into steroid use in Australia, and for 
appropriate and effective social and public health 
responses to steroid use? 
3.  Are you aware of any social research being 
conducted into steroid use in Australia? Has any of 
this work struck you as especially productive? If so, 
how? 
4.  Are there gaps in Australia’s knowledge about 
steroid use, and if so what are they?
5.  In general, how would you describe the current fit 
between research on steroid use and policy and 
practice in Australia? 
6.  Our work is concerned with the spread of blood-
borne viruses through steroid injecting. In a 
new study we’re planning, we aim to interview 
people who inject steroids to learn more about 
their practices, the risks of transmission and 
opportunities for intervention. This includes 
exploring the best ways to deliver harm reduction 
advice and information to people who inject 
steroids. 
a. FOR SERVICE PROVIDERS AND POLICY: Do you 
have any suggestions for enhancing the relevance 
of the study to your work? Do you have any 
suggestions for strengthening the link between the 
study and the key issues you have identified? 
b. FOR ACADEMICS: Do you have any suggestions 
for strengthening the link between the study and 
the key issues you have identified?
7.  Much about the steroid debate currently inspires 
controversy. What is your view on the disagreement 
surrounding the true scale of steroid use?
8.  We aim to ensure our planned project effectively 
draws on policy and service provider expertise in 
formulating and implementing the research and 
its outcomes. Can you recommend ways in which 
this would be best achieved? We’re keen to consider 
innovative ideas to ensure the research is as useful 
and accessible as possible.
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